News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
663,586 Results
Type
Article (52213)
Company Profile (406)
Press Release (610967)
Section
Business (186838)
Career Advice (2505)
Deals (33270)
Drug Delivery (109)
Drug Development (81314)
Employer Resources (152)
FDA (16237)
Job Trends (14550)
News (325444)
Policy (32012)
Tag
Academia (2822)
Alliances (47703)
Alzheimer's disease (1375)
Approvals (16177)
Artificial intelligence (183)
Bankruptcy (346)
Best Places to Work (11487)
Biotechnology (310)
Breast cancer (212)
Cancer (1572)
Cardiovascular disease (135)
Career advice (2110)
CAR-T (115)
Cell therapy (331)
Clinical research (64911)
Collaboration (594)
Compensation (241)
COVID-19 (2644)
C-suite (144)
Data (1493)
Diabetes (191)
Diagnostics (6135)
Earnings (68709)
Employer resources (139)
Events (100542)
Executive appointments (492)
FDA (17023)
Funding (530)
Gene therapy (239)
GLP-1 (686)
Government (4536)
Healthcare (19242)
Infectious disease (2744)
Inflammatory bowel disease (127)
Interviews (526)
IPO (15244)
Job creations (3509)
Job search strategy (1740)
Layoffs (441)
Legal (7143)
Lung cancer (236)
Manufacturing (210)
Medical device (13974)
Medtech (13978)
Mergers & acquisitions (18273)
Metabolic disorders (532)
Neuroscience (1767)
NextGen: Class of 2025 (6724)
Non-profit (4563)
Northern California (1805)
Obesity (301)
Opinion (220)
Patents (138)
People (57614)
Phase I (20280)
Phase II (28561)
Phase III (21361)
Pipeline (619)
Postmarket research (2603)
Preclinical (8630)
Radiopharmaceuticals (257)
Rare diseases (304)
Real estate (5410)
Regulatory (21963)
Research institute (2483)
Resumes & cover letters (364)
Southern California (1599)
Startups (3591)
United States (16374)
Vaccines (590)
Weight loss (229)
Date
Last 7 days (666)
Last 30 days (1853)
Last 365 days (35091)
2025 (1572)
2024 (35539)
2023 (39945)
2022 (51065)
2021 (55252)
2020 (53910)
2019 (46959)
2018 (35480)
2017 (32615)
2016 (31676)
2015 (37022)
2014 (29497)
2013 (24697)
2012 (26269)
2011 (26875)
2010 (24895)
Location
Africa (835)
Arizona (179)
Asia (40052)
Australia (7519)
California (4171)
Canada (1525)
China (357)
Colorado (186)
Connecticut (205)
Europe (89042)
Florida (587)
Georgia (145)
Illinois (429)
Indiana (234)
Maryland (707)
Massachusetts (3194)
Michigan (185)
Minnesota (318)
New Jersey (1186)
New York (1174)
North Carolina (813)
Northern California (1805)
Ohio (152)
Pennsylvania (953)
South America (1140)
Southern California (1599)
Texas (589)
Utah (121)
Washington State (419)
663,586 Results for "precision therapeutics formerly known as skyline medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach
January 14, 2025
·
4 min read
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
Press Releases
Skyline Therapeutics’ Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa
September 3, 2024
·
3 min read
Press Releases
Molecular Switches Revolutionizing Drug Development & Therapeutic Precision
January 8, 2025
·
1 min read
Drug Development
Beacon Therapeutics Announces Positive 24-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosa
October 15, 2024
·
4 min read
Press Releases
Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
January 7, 2025
·
1 min read
Business
Function Oncology Announces Innovative Precision Medicine Partnership with Volastra Therapeutics
Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, announced an innovative research and development partnership with Volastra Therapeutics, a company pioneering novel approaches to treating cancer by targeting a tumor vulnerability known as chromosomal instability.
March 26, 2024
·
2 min read
Drug Development
Beacon Therapeutics Announces Positive 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosa
Beacon Therapeutics Holdings Limited announced the presentation of 12-month interim safety and efficacy results for the Phase 2 SKYLINE trial in patients with X-linked retinitis pigmentosa (XLRP) at the 47th Annual Macula Society Meeting in Palm Springs, California.
February 8, 2024
·
3 min read
Press Releases
ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
January 10, 2025
·
8 min read
Immunology and inflammation
Gilead Continues Diversification Drive With Potential $1.7B Inflammation Pact With LEO
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 and IL-13 signaling, which in turn are known inflammatory targets.
January 13, 2025
·
2 min read
·
Tristan Manalac
1 of 66,359
Next
